Consistent with previous studies on mice with different cancer types, such as MC38 and B16 (refs. 51,52), blockade of A2ARs led to a significant reduction in CRPC growth, potentially resulting from a significantly lower frequency and number of exhausted CD8+ T cells (CD38+PD-1+; Extended Data Fig. 8a–c). The gene discussed is PDCD1; the disease is cancer.